司美格鲁肽能减少动物的肝脏炎症和瘢痕形成，暗示了潜在的低剂量治疗方案。 Semaglutide reduces liver inflammation and scarring in animals, suggesting potential lower-dose treatments.

新研究显示, 像Ozempic和Wegovy这样的流行的减肥药物可以改善肝脏健康. New research reveals that popular weight-loss drugs like Ozempic and Wegovy improve liver health independently of weight loss. 科学家发现, 黄胺的活性成分直接攻击肝脏特种细胞以减少炎症和痕, 即使在没有减肥的动物身上. Scientists found that the active ingredient, semaglutide, directly targets specialized liver cells to reduce inflammation and scarring, even in animals that did not lose weight. 这一发现表明,这些药物可以用较低的剂量来减少副作用和治疗肝病时的成本. This discovery suggests the drugs could be used at lower doses to reduce side effects and costs while treating liver disease.